243
Views
4
CrossRef citations to date
0
Altmetric
Letter

A 2017 update: Challenging the cosmetic procedural delay following oral isotretinoin therapy

ORCID Icon, , &
Pages 58-60 | Received 21 Oct 2017, Accepted 20 Feb 2018, Published online: 28 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Edileia Bagatin, Marco Alexandre Dias da Rocha, Thais Helena Proença Freitas & Caroline Sousa Costa. (2021) Treatment challenges in adult female acne and future directions. Expert Review of Clinical Pharmacology 14:6, pages 687-701.
Read now
Edileia Bagatin & Caroline Sousa Costa. (2020) The use of isotretinoin for acne – an update on optimal dosing, surveillance, and adverse effects. Expert Review of Clinical Pharmacology 13:8, pages 885-897.
Read now

Articles from other publishers (2)

Parvaneh Hatami, Kamran Balighi, Hamed Nicknam Asl, Azadeh Goodarzi & Zeinab Aryanian. (2023) Isotretinoin and timing of procedural interventions: Clinical implications and practical points. Journal of Cosmetic Dermatology 22:8, pages 2146-2149.
Crossref
Ediléia Bagatin, Caroline Sousa Costa, Marco Alexandre Dias da Rocha, Fabíola Rosa Picosse, Cristhine Souza Leão Kamamoto, Rodrigo Pirmez, Mayra Ianhez & Hélio Amante Miot. (2020) Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology. Anais Brasileiros de Dermatologia 95, pages 19-38.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.